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Meta-analysis methods have been widely used to combine results
from multiple clinical or genomic studies to increase statistical power
and ensure robust and accurate conclusion. Adaptively weighted Fisher’s
method (AW-Fisher) is an effective approach to combine p-values
from K independent studies and to provide better biological inter-
pretation by characterizing which studies contribute to meta-analysis.
Currently, AW-Fisher suffers from lack of fast, accurate p-value com-
putation and variability estimate of AW weights. When the number
of studies K is large, the 3K − 1 possible differential expression pat-
tern categories can become intractable. In this paper, we apply an
importance sampling technique with spline interpolation to increase
accuracy and speed of p-value calculation. Using resampling tech-
niques, we propose a variability index for the AW weight estimator
and a co-membership matrix to characterize pattern similarities be-
tween genes. The co-membership matrix is further used to categorize
differentially expressed genes based on their meta-patterns for further
biological investigation. The superior performance of the proposed
methods is shown in simulations. These methods are also applied to
two real applications to demonstrate intriguing biological findings.
1. Introduction. High-throughput biological experiments play a key
role in deciphering biological mechanisms behind complex diseases. Ad-
vanced experimental techniques allow us to obtain high-resolution genomic
information with affordable price. Over the years large amount of omics data
are accumulated in public databases and depositories: The Cancer Genome
Atlas (TCGA) http://cancergenome.nih.gov, Gene Expression Omnibus
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(GEO) http://www.ncbi.nlm.nih.gov/geo/ and Sequence Read Archive
(SRA) http://www.ncbi.nlm.nih.gov/sra/, just to name a few. For a
given transcriptomic study from microarray or RNA-seq, many statistical
methods have been developed for detecting differentially expressed (DE)
genes as candidate biomarkers (Pan, 2002; Soneson and Delorenzi, 2013).
The analysis of single study, however, contains small to moderate sample
size (usually N = 20 ∼ 50), producing unstable and inaccurate results (Si-
mon et al., 2003; Simon, 2005; Domany, 2014). Meta-analysis to combine
multiple transcriptomic studies has become a common practice to improve
statistical power and reproducibility. Interested readers may refer to Ra-
masamy et al. (2008) for a practical guideline of microarray meta-analysis,
and Tseng, Ghosh and Feingold (2012); Begum et al. (2012) for compre-
hensive reviews of microarray and genome-wide association study (GWAS)
meta-analysis.
Among the numerous meta-analysis methods proposed in the literature,
combining p-values from multiple studies is a simple and flexible solution to
combine studies of different experimental design and avoid complexity from
batch effect (e.g. different studies utilize different platforms or experimental
protocols). Multiple hypothesis settings have been considered to address
different biological questions. According to Song and Tseng (2014) (see also
Birnbaum (1954); Li and Tseng (2011)), three major hypothesis settings
have been considered in the literature: HSA targets on detecting biomarkers
that are differentially expressed in all cohorts (H0 : ~θ ∈
⋂{θk = 0} vs
HA : ~θ ∈
⋂{θk 6= 0}, where θk is the effect size of study k, 1 ≤ k ≤ K);
HSB targets on biomarkers differentially expressed in one or more studies
(H0 : ~θ ∈
⋂{θk = 0} vs HA : ~θ ∈ ⋃{θk 6= 0}); HSr targets on biomarkers
differentially expressed in at least r studies (H0 : ~θ ∈
⋂{θk = 0} vs HA :∑
I{θk 6= 0} ≥ r, where I{·} is an indicator function taking value one if
the statement is true and zero otherwise and r is usually pre-specified with
K/2 ≤ r ≤ K). Biologically HSA is preferred when the purpose is to find
concordant genes across all studies. HSr can be considered as a robust form of
HSA to seek for concordant genes in majority of studies. On the other hand,
HSB is considered when heterogeneity is expected and we are interested in
biomarkers statistically significant in at least one study.
In the literature, HSB is a union-intersection test (UIT, Roy (1953)) and is
also called a conjunction or intersection hypothesis (Benjamini and Heller,
2008). Many statistical tests have been developed for this hypothesis set-
ting, including Fisher’s method (Fisher, 1934), Stouffer’s (Stouffer et al.,
1949) method, minimum p-value method (Tippett, 1931) and many oth-
ers. Fisher’s method defines the test statistic by sum of log-transformed
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p-values: TF = −2∑Kk=1 log pk, where pk is the p-value from the kth study;
Stouffer’s method uses TS = − 1√
K
∑K
k=1 Φ
−1(pk) where Φ−1(·) is the in-
verse CDF of standard normal distribution. A larger Fisher (or Stouffer)
score indicates stronger differential expression evidence. Under the null as-
sumption and assuming independence across studies, the null distribution
of Fisher’s statistics follows χ22K and Stouffer’s follows N(0, 1). Although
Fisher’s method has many theoretical advantages (e.g. asymptotic Bahadur
optimality under certain restricted Gaussian assumptions; see Littell and
Folks (1971)), it has a critical pitfall when heterogeneity is expected across
studies. For example, suppose ~p1 = (0.001, 1, 1) represents p-values of three
studies of gene 1 and ~p2 = (0.1, 0.1, 0.1) represents p-values of gene 2. Both
genes produce the same Fisher’s test statistics and meta-analysis p-values
(TF = 13.8 and pF = 0.032) but the biological interpretations of the two
genes are obviously different. ~p1 indicates strong statistical significance only
in the first study, while ~p2 shows marginal statistical significance in all three
studies. To characterize study heterogeneity in meta-analysis, Li and Tseng
(2011) proposed an adaptively weighted Fisher’s method (AW-Fisher) where
the Fisher’s score is modified as weighted sum and the 0-1 weights can be
viewed as latent variable of whether a study contributes DE information
to the meta-analysis (details see Section 2). Aside from additional biological
interpretation of AW weights, AW-Fisher also enjoys nice theoretical proper-
ties. It has been shown to be admissible (Li and Tseng, 2011) and asymptotic
Bahadur optimal under certain Gaussian assumptions (Park et al., 2017+).
In addition, Fisher’s method is more powerful when all studies are signifi-
cant and minimum p-value method is more powerful when only one study
has small p-value. AW-Fisher theoretically takes advantage of both meth-
ods on their favored extreme situations (Li and Tseng, 2011). Chang et al.
(2013) performed a comprehensive comparative study to evaluate 12 popu-
lar microarray meta-analysis methods and categorized them into the three
complementary hypothesis settings, HSA, HSB and HSr. AW-Fisher was the
best performer in the HSB setting when considering a variety of data and
heterogeneity assumptions.
Despite practical and theoretical advantages of AW-Fisher, currently there
exist three major issues when applying the method. Firstly, p-value calcu-
lation of AW-Fisher has no simple closed-form solution. Permutation anal-
ysis is slow and generates low numerical precision of p-values to effectively
account for multiple comparisons when thousands of genes are tested si-
multaneously (Sun and Wright, 2010). Secondly, the weight estimate for
AW-Fisher is a hard classification (i.e. decision of 0 or 1) and is lack of
a variability estimate of the weight. Finally, when number of studies K is
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large, the number of biomarker categories by AW-Fisher weights increases
exponentially and becomes intractable. In this paper, we develop method-
ologies to overcome the three bottlenecks of AW-Fisher. In Section 2, we
introduce AW-Fisher and its existing issues in more detail. Section 3 de-
scribes an importance sampling technique with spline interpolation and a
linear weight search scheme to overcome computational burden. In Section 4,
we develop a bootstrap scheme to define a variability index of AW-Fisher
weight estimate. In Section 5, to overcome the exponential growth of num-
ber of biomarker categories, we extend the bootstrap scheme to obtain a
co-membership matrix to gauge the pattern similarity of resulting biomark-
ers. By applying tight clustering algorithm (Tseng and Wong, 2005), tight
clusters of biomarkers with different meta-patterns are generated for insight-
ful biological interpretation and hypothesis generation. Section 6 shows two
real applications in mouse metabolism microarray data and HIV transgenic
rat RNA-seq data. Section 7 contains final conclusion and discussion.
2. AW-Fisher and its existing issues. Below we describe method
and rationale for AW-Fisher (Li and Tseng, 2011). Define T (~P; ~w) = −2∑Kk=1wk logPk,
where ~w = (w1, . . . , wK) ∈ {0, 1}K is the AW weight associated withK stud-
ies and ~P = (P1, . . . , PK) ∈ (0, 1)K is the random variable of input p-value
vector for K studies. Under the null distribution and conditional on ~w, the
significance level obtained by T (~P; ~w) is L(T (~P; ~w)) = 1−Fχ2
d(~w)
(T (~P; ~w)),
where d(~w) = 2
∑K
k=1wk and Fχ2d
(·) is the cumulative distribution function
(CDF) of χ2-distribution with degrees of freedom d. The test statistic of
AW-Fisher given p-value vector ~P is defined as
(2.1) s(~P) = min
~w
L(T (~P; ~w))
The optimal weight for wˆ is determined by wˆ = w(~P) = arg min~w L(T (~P; ~w)).
Here we denote by s the mapping from p-value vector to the AW-Fisher test
statistic and S is the random variable for AW-Fisher test statistic which can
be obtained by S = s(~P). We further define signed AW-Fisher weights by
vˆ = (vˆ1, . . . , vˆK) = (wˆ1 · sign(θˆ1), . . . , wˆK · sign(θˆK)),
where (θˆ1, . . . , θˆK) is the estimate of effect size of each study and sign(x) =
x/|x| if x 6= 0 and sign(x) = 0 otherwise. Note that vˆk can be 0, 1 or -1 for
1 ≤ k ≤ K. AW-Fisher is appealing in applications since the AW weight
estimate wˆ characterizes which study contributes to the meta-analysis re-
sult. In the previous simple example, we have wˆ = (1, 0, 0) for gene 1 and
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wˆ = (1, 1, 1) for gene 2, which indicates gene 1 (~P = (0.001, 1, 1)) is a first-
study-specific biomarker while gene 2 (~P = (0.1, 0.1, 0.1)) is an all-study-
consistent biomarker. Figure 1A shows heatmap of candidate biomarkers
declared as DE by AW-Fisher’s method in a mouse metabolism microar-
ray example combining three studies (tissues): brown fat, heart, liver (see
Section 6.1). In each study, VLCAD-/- mutant mice (orange bar on top)
were compared to VLCAD+/+ wild-type mice (black bar) and DE analy-
sis was performed using Limma (Smyth, 2005). Meta-analysis p-values were
calculated for each gene using AW-Fisher method. Benjamini-Hochberg’s
procedure (Benjamini and Hochberg, 1995) was used to account for multi-
ple comparisons and false discovery rate was controlled at 5% level. Among
detected biomarkers, some genes are up-regulated DE genes across all tissues
(e.g. genes in module I, vˆ = (1, 1, 1))); many others are tissue specific (e.g.
heart-specific biomarkers in module III, vˆ = (0, 1, 0)). If applying Fisher’s
method, these different gene modules will not be distinguished, which may
hinder biologists for further biological investigation and hypothesis genera-
tion. Despite the advantages of AW-Fisher in theory and applications, ap-
plying AW-Fisher currently encounter three major issues outlined below.
I In the original paper, Li and Tseng (2011) did not derive a closed-
form solution for calculating null distribution of AW statistic. Instead,
permutation method (permuting case/control labels in each study in-
dependently) was suggested. This results in high computing demand,
especially high p-value numerical precision is needed to account for
multiple comparisons. The searching space of all possible weights also
becomes high (2K − 1) when K goes large. This will limit AW-Fisher
in general genomic applications.
II The AW weight estimate can generate unexpected discontinuity and
is thus not stable. For example, the following two genes were taken
from the mouse metabolism example in Figure 1. P-values of the three
tissues for probeset 1419484 a at were (0.000391, 0.0962, 0.00211), and
p-values for probeset 1425567 a at were (0.000356, 0.1026, 0.00206). De-
spite their very similar p-value inputs, 1419484 a at ended up with AW
weight wˆ = (1, 1, 1) with p-value 5.64 × 10−5 using AW-Fisher and
1425567 a at produced AW weight wˆ = (1, 0, 1) with p-value 5.22 ×
10−5, showing unstable weight estimate of the second study. In other
words, the AW weight estimate is a hard classification with no variabil-
ity estimate and biomarker categorization is thus unstable.
III Given K studies, the resulting genes could be categorized into (3K −
1) groups based on their unique AW weight estimate and effect size
direction (if separating up-regulation and down-regulation into 1 and
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Fig 1. Six meta-pattern modules of biomarkers from mouse metabolism example. Each
gene module (Module I, II, . . . , VI) shows a set of detected biomarkers with similar meta-
pattern of differential signals. (A) Heatmaps of detected genes (on the rows) and samples
(on the columns) for each tissue (brown fat, heart, liver), where each tissue represents
a study. Black color bar on top represents wild type (control) and orange color bar on
top represents VLCAD -/- mice (case). Number of genes is shown on the left under each
module number. (B) Variability index (genes on the rows and studies on the columns).
Variability index is described in Section 4. Gray heatmap range from 0 (black) to 1 (white),
which is the maximum of the variability index. Genes of each module are sorted based on
the mean variability index. (C) Signed AW-Fisher weights vˆgk for gene g and study k.
Light blue represents vˆgk = 1, yellow corresponds to vˆgk = −1 and black for vˆgk = 0.
Representative signed AW-Fisher weights for each module are shown on the right. Note
Brown represents brown fat tissue.
ISSUES IN AW-FISHER 7
-1 weight using vˆ; see Figure 1). This becomes intractable for further
biological investigation when K is large. For example, combining K = 5
studies produces 35 − 1 = 242 categories of biomarkers.
To solve these issues of AW-Fisher’s method, we will present methods for
fast p-value computing, variability index, biomarker categorization in the
following three sections.
3. Fast computing of AW-Fisher. In this section we will give solu-
tions to the two computational problems mentioned in Issue I. We propose
a fast algorithm of searching the adaptive weights in Section 3.1 and an
interpolation approach to obtain accurate p-values in Section 3.2. In Sup-
plementary Section I, we also derive closed-form solution for the cases K = 2
to benchmark the performance of the proposed method and K = 3 for the
purpose of demonstrating difficulties of closed-form solution in general K.
3.1. An almost-linear order fast searching algorithm for AW weight wˆ.
Recall that the searching space Ω = {~w : ~w 6= 0, ~w = (w1, . . . , wK) ∈
{0, 1}K} contains 2K−1 non-zero vectors of weights and searching the whole
space Ω to find the AW-Fisher test statistic s(~P) = min~w∈Ω L(T (~P; ~w)) and
the adaptive weights w(~P) = arg min~w∈Ω L(T (~P; ~w)) becomes computation-
ally expensive when K is large. The amount of computation is even more
challenging when the AW-Fisher’s method is applied to genomic data, where
the same procedure is repeated for thousands of genes or even millions of
SNPs. To overcome this difficulty, we propose a fast algorithm to find wˆ
based on the ordered p-values {P(i)}Ki=1 with P(1) ≤ . . . ≤ P(K). Specifically,
by decomposing Ω into Ω =
⋃K
k=1 Ωk with Ωk = {~w :
∑K
j=1wj = k}, it can
be seen that s(~P) = min~w∈Ω{L(T (~w; ~P))} = min1≤k≤K min~w∈Ωk{L(T (~w; ~P))}.
Given 1 ≤ k0 ≤ K, denote by ~wk0 = (wk01 , · · · , wk0K ) the vector of weights
such that −2∑Kj=1wk0j log(Pj) = −2∑k0j=1 log(P(j)) (i.e. the Fisher’s statis-
tics using the first k0 smallest p-values). Then it is straightforward to see
that the test statistic involving the first k0 ordered p-values will generate the
most significant L(T (~P; ~w)) in Ωk0 . This implies in Ωk0 , only ~w
k0 has to be
considered for further comparison. Therefore, instead of searching the whole
space Ω, it is enough to search only K vectors of weights {~w1, . . . , ~wK}
to find the adaptive weights wˆ. The proposed fast algorithm contains two
steps: firstly sorting K p-values (usually with complexity of O(K) log(K))
and then searching K vectors of weights (with complexity of O(K)). There-
fore, the fast searching algorithm proposed in this section reduces the com-
putational complexity from O(2K) to O(K log(K)), which can significantly
reduce computing time when K is large.
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3.2. Importance sampling and interpolation by spline smoothing for fast
p-value calculation. Denote by ~pobs the observed p-values from individual
studies and sobs = s(~pobs) the observed AW-Fisher statistics. Theoretically,
the p-value of AW-Fisher’s method PH0(S ≤ sobs) can be calculated an-
alytically for any K ≥ 2. However, the formulae involves the evaluation
of a K-fold integral and the integration domain becomes very complicated
for K ≥ 3, which makes the derivation of the closed-form solution tedious
and fallible. For illustration, closed-form derivation of K = 2 and K = 3
are shown in Supplementary materials. In Li and Tseng (2011), a permuta-
tion test by randomly permuting class labels in each study was proposed.
Although this non-parametric approach has its merit of maintaining gene
dependency structure, it is computationally demanding and difficult for gen-
erating precise small p-value, such as when p-value < 10−4, which is a critical
requirement for multiple testing correction on thousands of genes. In this
paper, we propose to use importance sampling to obtain an accurate nu-
merical approximation of PH0(S ≤ sobs). Importance sampling is a method
to accurately estimate expectation of a function with very small value us-
ing Monte Carlo sampling method. The idea behind importance sampling
is to draw samples from a suitable new distribution function rather than
the original one of interest and assign a weight to each sample based on the
ratio of two density functions.
To evaluate AW-Fisher p-valuePH0(S ≤ sobs) using importance sampling,
we propose a beta-distribution density function f∗(·) to draw ~P instead of
natural uniform distribution f(·) so that we can “over-sample” those small
p-values that result in a large S. It holds that
PH0(S ≤ sobs) = EH0 [I{S ≤ sobs}](3.1)
=
∫
I{S ≤ sobs}f(~P)d~P
=
∫
I{S ≤ sobs} f(
~P)
f∗(~P)
f∗(~P)d~P
= E∗[I{S ≤ sobs} ×W (~P)],
where f(·) is the density of ~P under the null and f∗(·) is the proposed den-
sity function of ~P for importance sampling. Importance sampling weight
W (·) = f(·)/f∗(·), E(·) and E∗(·) are the expectation with respect to
f(·) and f∗(·) respectively. Therefore, we can obtain expectation from the
original measure using a more efficient new one by applying weights for
different samples in Monte-Carlo method. Under the null hypothesis and
independence assumption between different studies, Pk ∼ UNIF(0, 1) for
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all 1 ≤ k ≤ K, so the joint distribution of f(~P) = 1. If we instead use
Beta(η, 1) distribution as the proposed distribution of each study for impor-
tance sampling, then f∗(~P) = ηK(
∏K
k=1 Pk)
η−1. To implement importance
sampling, suppose we simulate ~pi = (pi1, . . . , piK), where pik
i.i.d.∼ Beta(η, 1)
for 1 ≤ i ≤ n and 1 ≤ k ≤ K. Denote by si = s(~pi). From Equation 3.1, we
calculate estimate of PH0(S ≤ sobs) by
(3.2)
PˆH0(S ≤ sobs; η, ~p1, . . . , ~pn) =
1
n
·
n∑
i=1
(
I{si ≤ sobs} · 1
ηK(
∏K
k=1 pik)
η−1
)
Our p-value evaluation procedure has the following steps:
1. Specify targeted K = 2, 3, . . . , 100 and targeted AW-Fisher p-values as
{ct, t = 1, 2, . . . , 198} = {1, 0.99, 0.98, 0.97, . . . , 0.03, 0.02, 0.01, 10−3,
10−4, 10−5, . . . , 10−100}.
2. (Identify suitable η for given ct and K) Note that different η can
provide better importance sampling for different range of targeted ct
given K. To identify an appropriate η given ct and K, we simulate
~qi = (qi1, . . . , qiK), where 1 ≤ i ≤ 1000 and qik i.i.d.∼ Unif(0, 1). Denote
by ~qηi = (q
η
i1, . . . , q
η
iK) with element-wise power to η and r
(η)
i = s(~q
η
i ).
Define r0 = median1≤i≤1000(r
(η)
i ). Note that since qik
i.i.d.∼ Unif(0, 1),
qηik ∼ Beta(η, 1). From Equation 3.2, we have
φ(η) = PˆH0(S ≤ r0; η, ~qη1 , . . . , ~qη1000)
=
1
1000
·
1000∑
i=1
(
I{r(η)i ≤ r0} ·
1
ηK(
∏K
k=1 q
η
ik)
η−1
)
We choose η(K, ct) as the root of φ(η) = ct, which can be numerically
obtained using “uniroot()” function in R. This choice of η guarantees
half of the simulated samples will effectively contribute to the impor-
tance sampling calculation for each targeted ct. However, for ct ≥ 0.01,
we set η = 1 since the gain of importance sampling diminishes.
3. (Derive corresponding AW-Fisher statistics for targeted p-value ct)
Next, we derive the corresponding AW-Fisher statistic SK,t for a tar-
geted p-value ct given K. Given K and ct, we use η(K, ct) (abbrevi-
ated as η hereafter) from the previous step to draw ~oi = (oi1, . . . , oiK),
where 1 ≤ i ≤ 107 and ~oi i.i.d.∼ Beta(η, 1). Denote by ti = s(~oi) the
corresponding AW-Fisher statistic of ~oi and t(1) ≤ t(2) ≤ . . . ≤ t(107)
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are ordered from t1, . . . , t107 . Define
mi = PˆH0(S ≤ t(i); η, ~o1, . . . , ~o107)
=
1
107
·
107∑
j=1
(
I{tj ≤ t(i)} ·
1
ηK(
∏K
k=1 ojk)
η−1
)
Note that mi is monotonically decreasing with m1 = 1 and m107 ≈ 0.
There exists i∗ such that mi∗ ≤ ct < mi∗+1. The corresponding AW-
Fisher statistic SK,t given K and ct is chosen as SK,t = t(i
∗).
4. (Interpolation to calculate p-value of a given Sobs) From Step 3, the
library of ct and SK,t (t = 1, . . . , 198 and K = 2, . . . , 100) is estab-
lished for interpolation. For any given AW-Fisher statistic Sobs and
K, we apply function “splinefun” in R with “monoH.FC” option using
(log(SK,t), log(ct)), where t = 1, 2, . . . , 198, to fit a smooth curve and
identify the corresponding p-value of Sobs. Note that we apply spline
on log-scale p-value to avoid numerical overflow.
Remark. In Step 2, given K, we simulate qik
i.i.d.∼ Unif(0, 1) and take
the power of η, instead of simulating from Beta(η, 1). This design guarantees
φ(η) is a monotone function with respect to η by eliminating the uncertainty
from sampling qik for each η.
For any future input p-values, we only need to calculate the AW-Fisher
statistics and interpolate the statistics to obtain AW-Fisher p-value by the
spline curve fitting. The design of our base library {(log(SK,t), log(ct));
(t = 1, . . . , 198, and K = 2, . . . , 100)} facilitates accurate estimation for
AW-Fisher p-value up to precision of 10−100 and K up to 100. Although the
computation is demanding to generate the base library, it only runs once
before we generate our AW-Fisher R package and will not affect computing
for users. In fact, it took 6373.5 CPU hours using AMD Opteron(tm) Pro-
cessor (1.4GHz) to accomplish the whole base library with 107 samples for
all K ′s and t′s.
3.3. Simulation and numerical evaluation. In section 3.2 we introduced
fast computing for AW-Fisher p-value via importance sampling and interpo-
lation by spline smoothing. In this section, this interpolation approach will
be compared to the original permutation-based approach in Li and Tseng
(2011) and Wang et al. (2012). The comparisons include evaluation of ac-
curacy and computing speed. In terms of computing speed, our approach
applies a new linear sorting algorithm for searching weights and an interpo-
lation for p-value calculation. The improvement of linear sorting algorithm is
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quite obvious: the searching space reduces from an exponential order O(2K)
to almost linear order O(K log(K)). Below we utilize the closed-form solu-
tion for K = 2 in Appendix as the underlying truth to compare the new
approach with the existing permutation approach. The linear sorting does
not improve computing speed when K = 2 and the improvement will mainly
come from the interpolation. Our simulation setting is as follows:
1. Simulate K = 2 studies, G = 10, 000 genes and 2N subjects (N =
20, 50) with N cases and N controls.
2. Firstly, we simulated correlated gene structure and assumed no effect
size for any gene or any study. The procedure generally follows Song
and Tseng (2014).
(a) For the first 4,000 genes, simulate 200 gene modules with 20 genes
in each module and the remaining 6,000 genes are uncorrelated.
Denote by Cg ∈ {0, 1, . . . , 200} the cluster membership indicator
for gene g (e.g. Cg = 1 indicates gene g is in module 1 while
Cg = 0 indicates gene g is not in any gene module).
(b) For module c and study k, simulate A′ck ∼ W−1(Φ, 60), where
1 ≤ c ≤ 200, Φ = 0.5I20×20 + 0.5J20×20, W−1 denotes the inverse
Wishart distribution, I is the identity matrix and J is the matrix
with all elements equal to 1. Ack is calculated by standardizing
A′ck such that the diagonal elements are all 1’s. The covariance
matrix for gene module c in study k is calculated as Σck = Ack.
(c) Denote by gc1, . . . , gc20 the indices of the 20 genes in module c
(i.e. Cgcj = c, where 1 ≤ c ≤ 200 and 1 ≤ j ≤ 20). Simulate
expression levels of genes in module c for sample n in study k
as (X ′gc1kn, . . . , X
′
gc20kn
) ∼ MVN(0,Σcs), where 1 ≤ n ≤ 2N and
1 ≤ k ≤ K. For any uncorrelated gene g with Cg = 0, simulate
the expression level for sample n in study k as X ′gkn ∼ N(0, σ2),
where 1 ≤ n ≤ 2N and 1 ≤ k ≤ K.
3. Simulate effect sizes and their DE directions for differentially expressed
(DE) genes.
(a) Assume that the first G1 genes are DE in at least one of the com-
bined studies, where G1 = 30% × G. For each 1 ≤ g ≤ G1, sim-
ulate vg from discrete uniform distribution vg ∼ UNIF(1, . . . ,K)
and then randomly simulate subset vg ⊆ {1, . . . ,K} such that
|vg| = vg. Here vg is the set of studies in which gene g is DE.
(b) For any DE gene g(1 ≤ g ≤ G1), simulate gene-level effect size
θg ∼ N0.5+(1, 1), where Na+ denotes the truncated Gaussian dis-
12 Z. HUO ET AL.
tribution within interval (a,∞). Also simulate study-specific ran-
dom effect size θgk ∼ N(θg, 0.22).
(c) Simulate dg ∼ BIN(1, 0.5), where 1 ≤ g ≤ G1. Here dg is the DE
direction for gene g for majority of studies.
4. Add the directed effect sizes to the gene expression levels simulated in
Step 2. For control subjects (1 ≤ n ≤ N), set the expression levels as
Xgkn = X
′
gkn. For case subjects (N + 1 ≤ n ≤ 2N), if 1 ≤ g ≤ G1 and
k ∈ vg, we set the expression levels as Xgkn = X ′gkn + (−1)dgθgk.
Using the closed-form solution as the underlying truth, we evaluated the
performance of AW-Fisher p-value from the interpolation approach and the
permutation-based approach. To formally evaluate the accuracy, we utilized
root mean square error (rMSE):
rMSE =
√√√√ G1∑
g=1
(αg − βg)2/G1,
where αg is the − log10 (AW-Fisher p-value) for gene g from the permuta-
tion approach or the interpolation approach, βg is the − log10 (AW-Fisher
p-value) for gene g from closed-form solution and the rMSE indicates the
accuracy of p-value estimates with smaller rMSE for better estimation. The
result for N = 20 is shown in Table 1 and the result for N = 50 is in Sup-
plementary Table 1. Clearly our proposed interpolation approach is superior
to permutation-based approach in terms of both accuracy and computing
time. Note that the interpolation approach is even faster than closed-form
solution because the interpolation is only based on spline curve fitting using
data in the library and does not implement Monte Carlo importance sam-
pling method while the closed form method requires evaluation of power and
logarithmic functions.
4. Variability index of adaptive weights.
4.1. Method for Variability index. As discussed in Issue II in the Sec-
tion 2, the AW weight estimate wˆg = (wˆg1, . . . , wˆgK) is discontinuous as
a function of the input p-values and thus may not be stable. Denote by
Ugk = 4 ·Var(wˆgk) the variability index of AW weight estimate for gene g in
study k. The variability index gauges the stability of wˆgk, where a smaller
variability index indicates a stable AW weight estimate. However, Ugk is not
easy to evaluate since wˆgk is binary. Here, we propose a bootstrap procedure
to calculate an estimate of Ugk. The procedure is as follows:
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Table 1
AW-Fisher p-value accuracy and computing time comparing interpolation approach and
permutation-based approach with N = 20. Closed form solution is displayed as
benchmark. B is number of permutations, where closed form solution and interpolation
approach don’t require any permutation. Interquartile shows the AW-Fisher p-value range
in − log10 scale using closed form solution. q1 and q3 represent 1st and 3rd quartile.
rMSE represents root mean squared error.
Method B interquartile(q1 ∼ q3) rMSE time
closed form NA 1.51∼11.4 NA 0.042 secs
interpolation NA 1.51∼11.4 0.00145 0.0115 secs
permutation
10000 1.51∼11.4 10.3 2.75 hours
1000 1.51∼11.4 10.8 9.52 mins
100 1.51∼11.4 11.4 58.9 secs
1. Obtain a bootstrap sample and repeat the following procedure B (b =
1, . . . , B) times.
• Denote by Dk ∈ RG×Nk the data matrix of study k, where G
is total number of genes and Nk is total number of samples for
study k. cki is the case-control label, where i ∈ {1, . . . , Nk} is the
sample index and cki = 0 or 1, representing sample i belongs to
control or case group.
• Create an empty data matrix D(b)k ∈ RG×Nk . Then sample the ith
column of D
(b)
k using j
th column of Dk, where j ∈ {j′ : ckj′ = cki}.
This bootstrap procedure is stepped through for i = 1, . . . , Nk
with replacement (allowing D
(b)
k has identical columns).
• Use bootstrapped data matrix D(b)k to generate AW weight esti-
mate wˆ
(b)
gk and effect size estimate θˆ
(b)
gk .
2. Calculate the variability index estiamte Uˆgk of wˆgk for gene g in study
k, where Uˆgk =
4
B
∑B
b=1(wˆ
(b)
gk − 1B
∑B
b′=1 wˆ
(b′)
gk )
2.
Here Uˆgk ranges from 0 to 1 with Uˆgk = 0 represents wˆ
(b)
gk = wˆgk for all b,
which indicates stable estimate of AW weight. Uˆgk = 1 represents wˆ
(b)
gk = 0
for half of b′s and wˆ(b)gk = 1 for the other half of b
′s. A large variability index
indicates an unstable estimate of AW weight.
4.2. Simulation result. We followed the simulation setting in Section 3.3
to evaluate different combinations of biological variance (σ = 1, 1.5, 2) and
sample sizes (N = 20, 50, 80) for the performance of the variability index
in Figure 2. The result shows that when the dataset has smaller sample
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size or larger biological variation, the variability index becomes larger. Since
the variability index gauges the stability of AW weight estimate, it can be
seen that noisy datasets tend to generate large variability index. Back to
the two Affymetrix probes shown in Issue II of Section 2, the variability
index of wˆ = (1, 1, 1) in 1419484 a at is (0, 0.932, 0) and variability index of
wˆ = (1, 0, 1) in 1425567 a at is (0,0.936,0), showing unstable weight estimate
of the second study for both gene probes.
0.0
0.1
0.2
0.3
0.4
0.5
20 50 80
noise
1
1.5
2
Fig 2. Comparison table of variability index for different scenario (combination of sample
size and biological variance). Only differential expressed genes counting from each individ-
ual studies are considered. Height of each bar indicates the mean level of variability index
and error bar indicates the standard error.
5. Resampling-based ensemble clustering for biomarker catego-
rization.
5.1. Method for biomarker categorization. In order to categorize detected
genes into biomarker groups with similar differential meta-pattern (Issue III),
we extended the bootstrapping procedure in Section 4.1 to obtain a co-
membership matrix for all pairs of genes where each element of the co-
membership matrix represents a similarity of signed AW weight vˆ of two
genes. Specifically, denote by vˆ
(b)
gk = wˆ
(b)
gk · sign(θˆ(b)gk ) from Section 4.1. Define
co-membership matrix from each bootstrap sample b as W (b) ∈ RG×G with
elements W
(b)
gg′ = 1 if vˆ
(b)
gk = vˆ
(b)
g′k for all k, and W
(b)
gg′ = 0 otherwise. The final
co-membership matrix is defined as V =
∑B
b=1W
(b)/B. We further applied
tight clustering algorithm (Tseng and Wong, 2005) (“tight.clust” function
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within R package “tightClust”) to the co-membership matrix V to obtain
tight modules. Tight clustering is able to produce tight and stable gene
modules without forcing all genes into clusters. The resulting gene modules
show unique differentially expressed patterns across multiple studies (namely
meta-pattern). We perform the biomarker categorization (clustering) proce-
dure only on declared DE genes at certain false discovery rate cutoff. Genes
of each resulting module are then sorted by the variability index and visual-
ized by heatmaps. Below we perform simulation to demonstrate performance
of the resampling-based ensemble clustering for biomarker categorization.
5.2. Simulation result for biomarker categorization. To evaluate the per-
formance of biomarker categorization, we adopted a simulation procedure
similar to Section 4.2 and Huo, Song and Tseng (2017). We simulated S = 4
studies in total and 50 control subjects and 50 case subjects in each study.
Among the G = 10, 000 genes, we set 4% as homogeneously concordant DE
genes, differentially expressed with the same direction in all studies (all pos-
itive or all negative). We denote “homo+” as the homogeneously concordant
DE genes with all positive effect sizes and “homo−” as the homogeneously
concordant DE genes with all negative effect sizes. We also set another 4%
as study-specific DE genes - differential expressed only in one study. Among
them, 1/4 are DE genes only in the first study with positive effect sizes
(denoted as “ssp1+”), 1/4 are DE genes only in the first study with nega-
tive effect sizes (denoted as “ssp1−”), 1/4 are DE genes only in the second
study with positive effect sizes (denoted as “ssp2+”), and the rest 1/4 are
DE genes only in the second study with negative effect sizes (denoted as
“ssp2−”). The rest of the genes are non-DE (denoted as “nonDE”). The
biological variation parameter σ is set to 1 in this simulation.
We first applied the proposed AW-Fisher method to this simulated dataset.
We obtained 794 genes based on FDR at 5% under HSB. Co-membership of
these genes were calculated with B = 1, 000 and used as input for our gene
module detection using tight clustering algorithm. We identified 6 gene mod-
ules in these 794 genes. The detected gene modules are tabulated against
the true gene modules simulated in Table 2 (Module 0 contains scattered
genes not assigned to any of the six modules). The false discovery rate is
well controlled at 34/794 = 4.3% while the nominal FDR is 5%. The de-
tected gene modules clearly correspond to the true modules, and most of
the nonDE genes were left out as the noises. The meta-pattern, variability
index and AW weight estimates of these 6 modules are shown in Supplemen-
tary Figure 1. This simulation study showed that the proposed algorithm
can recover the underlying gene meta-pattern.
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Table 2
Contingency table of 794 detected DE genes with simulation underlying truth (on the
columns) and tight clustering result with 6 target modules (on the rows). 0 represents the
scattered gene group. 1 ∼ 6 represent 6 detected modules. Bolded numbers are genes with
correct assignment.
Module homo− homo+ ssp1− ssp1+ ssp2− ssp2+ nonDE
1 0 177 0 0 0 0 0
2 184 0 0 0 0 0 0
3 0 0 0 74 0 0 1
4 0 0 60 0 0 0 1
5 0 0 0 0 0 102 2
6 0 0 0 0 85 0 3
0 13 24 19 11 6 5 27
6. Transcriptomic meta-analysis applications. We applied our pro-
posed methods on two real meta-analysis examples. The first example uti-
lized gene expression of multi-tissue microarray studies with metabolism re-
lated knockout mice. The second example utilized multi-brain-region RNA-
seq studies with HIV transgenic rats. The sample sizes are shown in Sup-
plementary Table 2.
6.1. Mouse metabolism example. Very long-chain acyl-CoA dehydroge-
nase (VLCAD) deficiency was found to be associated with energy metabolism
disorder in children. Two genotypes of the mouse model - wild type (VL-
CAD +/+) and VLCAD-deficient (VLCAD -/-) - were studied for three
types of tissues (brown fat, liver and heart) with 3 to 4 mice in each geno-
type group. Total number of probesets from these three transcriptomic mi-
croarray studies is 14,495. Supplementary Table 2a shows details of the
study design and the data set is available in supplementary materials. Two-
sided p-values and effect size were calculated using Limma comparing wild
type (VLCAD +/+) versus mutant (VLCAD -/-) mice in each tissue. AW-
Fisher meta-analysis p-values were obtained and q-values were calculated
by applying Benjamini-Hochberg procedure. By controlling FDR at 5%, we
obtained 967 differentially expressed genes. We calculated the variability
index and generated gene co-membership matrix using resampling tech-
niques. We further applied tight clustering algorithm on the co-membership
matrix to identify gene modules with unique meta-pattern. In this exam-
ple, we successfully detected 6 gene modules with different meta-patterns
in Figure 1. For example, the first and second biomarker modules (gene
cluster I and II) are concordant genes that are up-regulated (or down-
regulated) in all tissues. The other biomarker modules have study-specific
differential patterns. For example, DE genes in gene module III are up-
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regulated in heart but not in brown fat or liver. To examine the biological
functions of these modules, we performed pathway enrichment analysis for
genes in each module using Fisher’s exact test. The pathway database was
downloaded from Molecular Signatures Database (MSigDB) v5.0 (http://
bioinf.wehi.edu.au/software/MSigDB/), where a mouse-version pathway
database were created by combining pathways from KEGG, BIOCARTA,
REACTOME and GO databases and mapping all the human genes to their
orthologs in mouse using Jackson Laboratory Human and Mouse Orthology
Report (http://www.informatics.jax.org/orthology.shtml). We sum-
marized the pathway detection result (see supplementary Excel file 1 for
detailed pathway information). Among the six gene modules with distinct
meta-patterns, module I is enriched in enzyme activities (e.g. GO COFAC-
TOR BINDING; p = 3.85 × 10−4); module II is enriched in pathways for
amino acid catabolism (e.g. REACTOME BRANCHED CHAIN AMINO
ACID CATABOLISM; p = 9.31 × 10−5); module III is enriched in defense
related pathways (e.g. DEFENSE RESPONSE; p = 2.11 × 10−6); mod-
ule IV is enriched in pathways of metabolism of amino acids (e.g. REAC-
TOME METABOLISM OF AMINO ACIDS; p = 2.36 × 10−3); module V
is enriched in stimulus related pathways (e.g. EXTERNAL STIMULUS;
p = 1.33 × 10−3); For module VI, we did not detect any significantly en-
riched pathways. Interestingly, all of these pathways are known to be related
to different aspects of metabolism, which indicates that our method is able
to detect homogeneous and heterogeneous gene modules that are biologi-
cally meaningful. The biomarker clustering result enhances meta-analysis
interpretation and motivates hypothesis for further biological investigation.
For example, it is intriguing why the defense related genes in module III
are up-regulated only in heart but not in liver and brown fat, and why the
stimulus related genes in module V are down-regulated in heart and liver
but not in brown fat.
6.2. HIV transgenic rat RNA-seq data. Li et al. (2013) conducted studies
to determine gene expression differences between F344 and HIV transgenic
rats using RNA-seq (GSE47474 in Gene expression Omnibus database http:
//www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE47474). The HIV
transgenic rat model is designed to study learning, memory, vulnerability to
drug addiction and other psychiatric disorders to HIV positive patients. 12
F334 untreated rats and 12 HIV transgenic rats in prefrontal cortex (PFC),
hippocampus (HIP), and striatum (STR) regions are sequenced for RNA-seq
(see Supplementary Table 2b. Tophat (Trapnell, Pachter and Salzberg, 2009)
was applied for alignment (adopted by Li et al. (2013)) and the alignment
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Fig 3. Three meta-pattern modules of biomarkers from HIV transgenic rats example.
Each gene module (Module I, II and III) shows a set of detected biomarkers with similar
meta-pattern of differential signals. (A) Heatmaps of detected genes (on the rows) and
samples (on the columns) for each brain region (HIP, PFC or STR). where each brain
region represents a study k. Black color bar on top represents F334 rats (control) and
orange color bar on top represents HIV transgenic rats (case). Number of genes is shown
on the left under each module number. (B) Variability index (genes on the rows and studies
on the columns). Variability index is described in Section 4, Gene modules, gray heatmap
range from 0 (black) to 1 (white), which is the maximum of the variability index. Genes of
each module are sorted based on the mean variability index. (C) AW weight result. Light
blue color represents AW weight 1 and up-regulation. Yellow color represents AW weight
1 and down-regulation. Black color represents AW weight 0. Genes are shown on the rows
and studies are shown on the columns Number of genes is shown on right of each module.
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results were converted to RNA-seq count data with 16,821 genes by bedtools
(Quinlan and Hall, 2010). Genes with less than 100 total counts within any
brain region were filtered out and 11,824 genes remained. Potential outliers
were removed by checking the sample correlation heatmaps (see Supplemen-
tary Figure 2). R package “edgeR” (Robinson, McCarthy and Smyth, 2010)
was adopted to perform differential expression gene detection and two-sided
p-values were obtained. AW-Fisher meta-analysis p-values were evaluated
and q-values were obtained by applying Benjamini-Hochberg procedure. By
controlling FDR at 30%, we obtained 145 differentially expressed genes.
We loose the FDR criteria to 30% since it is well known that the tran-
scriptomic signals in brain are generally weak. We calculated the variability
index and performed biomarker categorization by using resampling tech-
niques and tight clustering algorithm. The result is shown in Figure 3. To
examine the biological functions of these modules, we also performed path-
way enrichment analysis using the same procedure as in Section 6.1 (see
supplementary Excel file 2 for detailed information). As the results show,
module I is up-regulated in all the three brain regions, and is enriched in
pathways related to response to virus. (e.g. GO RESPONSE TO VIRUS;
p = 1.59× 10−3); module II is down-regulated in all the three brain regions,
and is enriched in pathways related to rhythmic process (e.g. GO RHYTH-
MIC PROCESS; p = 6.23× 10−4); module III is especially interesting since
it is down-regulated in HIP, but up-regulated in PFC and STR. However
we did not detect any significant pathways using MSigDB, possibly due to
small module size (only 15 genes). Instead we used a broader mouse path-
way database from Gene Ontology Consortium (Bares and Ge, 2015), which
contained broader pathway categories; we found that GO FOREBRAIN DE-
VELOPMENT and GO TELENCEPHALON DEVELOPMENT pathways
are highly associated with module III (p = 2.82×10−3 and p = 2.84×10−4).
Since the brain regions are affected by virus, we anticipate that genes re-
sponding to virus to be up-regulated, as observed in module I. The down-
regulation of rhythmic process genes in module II indicates that HIV virus
may have caused loss of rhythmic pattern in multiple brain regions. More-
over, because different brain regions have different functions, it is not sur-
prising that some brain development related genes (module III) respond
differently to HIV in different brain regions.
7. Conclusion and discussion. Emerging omics datasets in public do-
main has made genome-wide meta-analysis appealing. Adaptively weighted
Fisher’s method has become useful and popular in the stance that it will
characterizes study-specific contributions to the meta-analysis result. In this
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paper, we proposed fast computing and biomarker clustering methods to im-
prove application of AW-Fisher. The contributions of this paper are three-
fold: (1) Previous version of AW algorithm relied on permutation analysis
to assess p-values, which set a limitation for accuracy and speed. We pro-
posed a fast computing and weight searching algorithm for AW algorithm
based on importance sampling, interpolation and a linear searching complex-
ity of AW weight, which makes the AW-Fisher algorithm more applicable
for large-scale genomic applications. (2) We developed an AW-Fisher weight
variability index. This is essential to determine stability of AW-Fisher weight
estimates. (3) We proposed a biomarker categorization algorithm via a re-
sampling procedure, which can efficiently obtain gene modules of different
meta-analysis differential expression pattern (namely meta-patterns). These
meta-patterns can help establish biological hypothesis to quantify homo-
geneous and heterogeneous DE signals across studies and guide next-step
biological investigation. Finally, the the superior performances of the pro-
posed methods are demonstrated in simulation and two real applications
(mouse brain HIV RNA-seq data and mouse metabolism data).
We note that the adaptive weight concept can be extended from Fisher’s
method to other p-value combination meta-analysis methods, such as Stouf-
fer’s method. The linear weight searching, importance sampling and spline
smoothing can equally be applied in order to efficiently obtain accurate p-
values (e.g. AW-Stouffer’s method). An R package (calling C++) is available
https://github.com/Caleb-Huo/AWFisher and all datasets and program-
ming code used to perform all analyses in this paper are available on author’s
website.
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